As Christmas approaches, many households will be spending a little more time (and money) caring for the cherished pets they have. But behind the festive cheer sits a serious and growing theme: how we look after pet health and why innovation in diagnostics is becoming increasingly important for owners, vets and investors alike.

In the first of our special Christmas episodes, Jane Parry, Group Chief Marketing Officer, is joined by John Pullar-Strecker, Research Specialist in our Chief Investment Office, to explore the fast-growing world of pet health and diagnostics and why it matters from both a societal and investment perspective.

Together, they discuss:

• The sheer scale of pet ownership across the UK, Europe and the US

• Why rising insurance costs and the cost of living are putting pressure on pet owners

• How a global shortage of qualified vets is creating bottlenecks in care

• How advances in diagnostics - from blood analysis to oncology screening - can improve outcomes for pets

• Why companies providing diagnostic technology benefit from strong, recurring revenue models.

John explains why owners often prioritise their animals’ wellbeing over their own spending and how investing in pet health technology can support better care - while also offering attractive long-term investment characteristics.

If you have any feedback on this episode, the podcast overall or questions regarding future topics, please email . We’d love to hear from you.

Investment involves risk. The value of investments and the income from them can go down as well as up and you may not get back the amount originally invested. Past performance is not a reliable indicator of future performance.

The information provided is not to be treated as specific advice. It has no regard for the specific investment objectives, financial situation or needs of any specific person or entity. It is accurate at the time of recording and is subject to change.

Canaccord Wealth is the trading name of Canaccord Genuity Wealth Limited (CGWL), CG Wealth Planning Limited (CGWPL), Canaccord Genuity Wealth (International) Limited (CGWIL) and Canaccord Asset Management (International) Ltd (CAMIL), which are all subsidiaries of Canaccord Genuity Group Inc.

CGWL and CGWPL are authorised and regulated by the Financial Conduct Authority (reference numbers: 194927 and 594155). CGWL and CGWPL are registered in England & Wales at 88 Wood Street, London, EC2V 7QR (numbers 03739694 and 08284862).

CGWIL is licensed and regulated by the Guernsey Financial Services Commission, the Isle of Man Financial Services Authority and the Jersey Financial Services Commission. CGWIL is authorised by the Financial Sector Conduct Authority (FSCA) as a financial services provider in South Africa, FSP no. 48055. CGWIL is registered in Guernsey at Dorey Court, Elizabeth Avenue, St. Peter Port, Guernsey, GY1 2HT (number 22761).

CAMIL is licensed and regulated by the Jersey Financial Services Commission. Its Guernsey branch is licensed and regulated by the Guernsey Financial Services Commission and its Isle of Man branch is licensed and regulated by the Isle of Man Financial Services Authority. is authorised by the FSCA as a financial services provider in South Africa. Registered in Jersey No: 143275. Registered office: Third Floor, No 1 Grenville Street, St. Helier, Jersey, JE2 4UF.